Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2015Advances in TherapyOpen Access

Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice—EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study

View Full Paper
Ask AI
Bookmark
Share

Authors

JGJean–François GautierHôpital LariboisièreLML. MartínezInsermAPAlfred PenfornisUniversité Paris-Saclay

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gautier et al. (2015) studied this question.

synapsesocial.com/papers/6a73a3217af34f94aaa73535https://doi.org/10.1007/s12325-015-0245-x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment2014 · 497 citations
  2. 2Clinical Effects of Liraglutide in a Real-World Setting in Spain: eDiabetes-Monitor SEEN Diabetes Mellitus Working Group Study2015 · 23 citations
  3. 3Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme2012 · 101 citations
  4. 4GLP-1 receptor agonists in type 2 diabetes - NICE guidelines versus clinical practice2014 · 28 citations
  5. 5Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis2010 · 88 citations